BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 28935764)

  • 21. Reducing hyperactivated BAP1 attenuates mutant ASXL1-driven myeloid malignancies in human haematopoietic cells.
    Bai J; Chen Z; Chen C; Zhang M; Zhang Y; Song J; Yuan J; Jiang X; Xing W; Yang J; Bai J; Zhou Y
    Cancer Lett; 2021 Oct; 519():78-90. PubMed ID: 34186160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. BAP1: Not just a BRCA1-associated protein.
    Louie BH; Kurzrock R
    Cancer Treat Rev; 2020 Nov; 90():102091. PubMed ID: 32877777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substrate filtering by the active site crossover loop in UCHL3 revealed by sortagging and gain-of-function mutations.
    Popp MW; Artavanis-Tsakonas K; Ploegh HL
    J Biol Chem; 2009 Feb; 284(6):3593-602. PubMed ID: 19047059
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterizing substrate selectivity of ubiquitin C-terminal hydrolase-L3 using engineered α-linked ubiquitin substrates.
    Navarro MF; Carmody L; Romo-Fewell O; Lokensgard ME; Love JJ
    Biochemistry; 2014 Dec; 53(51):8031-42. PubMed ID: 25369561
    [TBL] [Abstract][Full Text] [Related]  

  • 25. BAP1: a novel ubiquitin hydrolase which binds to the BRCA1 RING finger and enhances BRCA1-mediated cell growth suppression.
    Jensen DE; Proctor M; Marquis ST; Gardner HP; Ha SI; Chodosh LA; Ishov AM; Tommerup N; Vissing H; Sekido Y; Minna J; Borodovsky A; Schultz DC; Wilkinson KD; Maul GG; Barlev N; Berger SL; Prendergast GC; Rauscher FJ
    Oncogene; 1998 Mar; 16(9):1097-112. PubMed ID: 9528852
    [TBL] [Abstract][Full Text] [Related]  

  • 26. BRCA1-associated protein 1 interferes with BRCA1/BARD1 RING heterodimer activity.
    Nishikawa H; Wu W; Koike A; Kojima R; Gomi H; Fukuda M; Ohta T
    Cancer Res; 2009 Jan; 69(1):111-9. PubMed ID: 19117993
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roles of the BAP1 Tumor Suppressor in Cell Metabolism.
    Han A; Purwin TJ; Aplin AE
    Cancer Res; 2021 Jun; 81(11):2807-2814. PubMed ID: 33446574
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Crystal structure of the catalytic domain of UCHL5, a proteasome-associated human deubiquitinating enzyme, reveals an unproductive form of the enzyme.
    Maiti TK; Permaul M; Boudreaux DA; Mahanic C; Mauney S; Das C
    FEBS J; 2011 Dec; 278(24):4917-26. PubMed ID: 21995438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ubiquitin dimers control the hydrolase activity of UCH-L3.
    Setsuie R; Sakurai M; Sakaguchi Y; Wada K
    Neurochem Int; 2009; 54(5-6):314-21. PubMed ID: 19154770
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Structure of the ubiquitin hydrolase UCH-L3 complexed with a suicide substrate.
    Misaghi S; Galardy PJ; Meester WJ; Ovaa H; Ploegh HL; Gaudet R
    J Biol Chem; 2005 Jan; 280(2):1512-20. PubMed ID: 15531586
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A fluorescence assay for elucidating the substrate specificities of deubiquitinating enzymes.
    Yin ST; Huang H; Zhang YH; Zhou ZR; Song AX; Hong FS; Hu HY
    Biochem Biophys Res Commun; 2011 Dec; 416(1-2):76-9. PubMed ID: 22086173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Proteomic analysis identifies novel binding partners of BAP1.
    Baas R; J van der Wal F; Bleijerveld OB; van Attikum H; Sixma TK
    PLoS One; 2021; 16(9):e0257688. PubMed ID: 34591877
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of BAP1 expression is associated with genetic mutation and can predict outcomes in gallbladder cancer.
    Hirosawa T; Ishida M; Ishii K; Kanehara K; Kudo K; Ohnuma S; Kamei T; Motoi F; Naitoh T; Selaru FM; Unno M
    PLoS One; 2018; 13(11):e0206643. PubMed ID: 30395583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retracted: Histone H2B ubquitination regulates retinoic acid signaling through the cooperation of ASXL1 and BAP1.
    Lee SW; Youn H; Kim EJ; Um SJ
    Mol Cell; 2013 Jul; 51(2):200-10. PubMed ID: 23850490
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rational Development and Characterization of a Ubiquitin Variant with Selectivity for Ubiquitin C-Terminal Hydrolase L3.
    Hewitt CS; Das C; Flaherty DP
    Biomolecules; 2022 Jan; 12(1):. PubMed ID: 35053210
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ubiquitin C-terminal hydrolase-activity is involved in sperm acrosomal function and anti-polyspermy defense during porcine fertilization.
    Yi YJ; Manandhar G; Sutovsky M; Li R; Jonáková V; Oko R; Park CS; Prather RS; Sutovsky P
    Biol Reprod; 2007 Nov; 77(5):780-93. PubMed ID: 17671268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Entropic stabilization of a deubiquitinase provides conformational plasticity and slow unfolding kinetics beneficial for functioning on the proteasome.
    Lee YC; Chang CY; Chen SY; Pan YR; Ho MR; Hsu SD
    Sci Rep; 2017 Mar; 7():45174. PubMed ID: 28338014
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Somatic alteration and depleted nuclear expression of BAP1 in human esophageal squamous cell carcinoma.
    Mori T; Sumii M; Fujishima F; Ueno K; Emi M; Nagasaki M; Ishioka C; Chiba N
    Cancer Sci; 2015 Sep; 106(9):1118-29. PubMed ID: 26081045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural Basis for the Activation of the Deubiquitinase Calypso by the Polycomb Protein ASX.
    De I; Chittock EC; Grötsch H; Miller TCR; McCarthy AA; Müller CW
    Structure; 2019 Mar; 27(3):528-536.e4. PubMed ID: 30639226
    [TBL] [Abstract][Full Text] [Related]  

  • 40. BAP1: case report and insight into a novel tumor suppressor.
    Ghosh K; Modi B; James WD; Capell BC
    BMC Dermatol; 2017 Nov; 17(1):13. PubMed ID: 29166932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.